Type I and Type IV allergy to unfractionated heparin and low-molecular-weight heparin with no reaction to recombinant hirudin.
Hallai
Nirmala
N
Department of Occupational Dermatology, Royal Gwent Hospital, Newport, Wales, UK. hallaisoman@yahoo.co.uk
Hughes
T Meirion
TM
Stone
Natalie
N
D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000209:etiology*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006629:Hirudins / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D006801:Humans; D011994:Recombinant Proteins / Q000008:administration & dosage*; D012307:Risk Factors; D013997:Time Factors
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006629:Hirudins; D011994:Recombinant Proteins; C083544:lepirudin